F. Fakhouri, J. Zuber, V. Frémeaux-bacchi, and C. Loirat, Haemolytic uraemic syndrome, Lancet Lond Engl, vol.390, pp.681-96, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02155934

V. Fremeaux-bacchi, F. Fakhouri, A. Garnier, F. Bienaimé, M. Dragon-durey et al., Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults, Clin J Am Soc Nephrol, vol.8, pp.554-62, 2013.

N. S. Merle, S. E. Church, V. Fremeaux-bacchi, and L. T. Roumenina, Complement system part I-molecular mechanisms of activation and regulation, Front Immunol, vol.6, p.262, 2015.

C. M. Legendre, C. Licht, and C. Loirat, Eculizumab in atypical hemolytic-uremic syndrome, N Engl J Med, vol.369, pp.1379-80, 2013.

M. Noris and G. Remuzzi, Genetics and genetic testing in hemolytic uremic syndrome/thrombotic thrombocytopenic purpura, Semin Nephrol, vol.30, pp.395-408, 2010.

S. E. Sartain, N. A. Turner, and J. L. Moake, TNF regulates essential alternative complement pathway components and impairs activation of protein c in human glomerular endothelial cells, J Immunol, vol.196, pp.832-877, 2016.

L. T. Roumenina, J. Rayes, M. Frimat, and V. Fremeaux-bacchi, Endothelial cells: source, barrier, and target of defensive mediators, Immunol Rev, vol.274, pp.307-336, 2016.

M. Frimat, F. Tabarin, J. D. Dimitrov, C. Poitou, L. Halbwachs-mecarelli et al., Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome, Blood, vol.122, pp.282-92, 2013.

L. T. Roumenina, M. Frimat, E. C. Miller, F. Provot, M. Dragon-durey et al., A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function, Blood, vol.119, pp.4182-91, 2012.

L. T. Roumenina, M. Jablonski, C. Hue, J. Blouin, J. D. Dimitrov et al., Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome, Blood, vol.114, pp.2837-2882, 2009.

L. T. Roumenina, J. Rayes, S. Lacroix-desmazes, and J. D. Dimitrov, Heme: modulator of plasma systems in hemolytic diseases, Trends Mol Med, vol.22, pp.200-213, 2016.

J. D. Belcher, C. Chen, J. Nguyen, L. Milbauer, F. Abdulla et al., Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease, Blood, vol.123, pp.377-90, 2014.

N. S. Merle, A. Grunenwald, M. Figueres, S. Chauvet, M. Daugan et al., Characterization of renal injury and inflammation in an experimental model of intravascular hemolysis, Front Immunol, vol.9, p.179, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01966724

F. F. Dutra and M. T. Bozza, Heme on innate immunity and inflammation, Front Pharmacol, vol.5, p.115, 2014.

R. Gozzelino, V. Jeney, and M. P. Soares, Mechanisms of cell protection by heme oxygenase-1, Annu Rev Pharmacol Toxicol, vol.50, pp.323-54, 2010.

A. R. Kinderlerer, I. P. Gregoire, S. S. Hamdulay, F. Ali, R. Steinberg et al., Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin, Blood, vol.113, pp.1598-607, 2009.

E. W. Ades, F. J. Candal, R. A. Swerlick, V. G. George, S. Summers et al., HMEC-1: establishment of an immortalized human microvascular endothelial cell line, J Invest Dermatol, vol.99, pp.683-90, 1992.

S. C. Satchell, C. H. Tasman, A. Singh, L. Ni, J. Geelen et al., Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF, Kidney Int, vol.69, pp.1633-1673, 2006.

K. J. Livak and T. D. Schmittgen, Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods San Diego Calif, vol.25, pp.402-410, 2001.

K. Morimoto, K. Ohta, A. Yachie, Y. Yang, M. Shimizu et al., Cytoprotective role of heme oxygenase (HO)-1 in human kidney with various renal diseases, Kidney Int, vol.60, pp.1858-66, 2001.

. R-core-team, R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, 2017.

H. Wickham, Elegant Graphics for Data Analysis, 2009.

M. Delvaeye, M. Noris, D. Vriese, A. Esmon, C. T. Esmon et al., Thrombomodulin mutations in atypical hemolytic-uremic syndrome, N Engl J Med, vol.361, pp.345-57, 2009.

M. Shimizu, K. Ohta, Y. Yang, A. Nakai, T. Toma et al., Glomerular proteinuria induces heme oxygenase-1 gene expression within renal epithelial cells, Pediatr Res, vol.58, pp.666-71, 2005.

A. Rubio-navarro, M. D. Sanchez-niño, M. Guerrero-hue, C. García-caballero, E. Gutiérrez et al., Podocytes are new cellular targets of haemoglobinmediated renal damage, J Pathol, vol.244, pp.296-310, 2018.

M. D. Maines and G. M. Trakshel, Tin-protoporphyrin: a potent inhibitor of hemoprotein-dependent steroidogenesis in rat adrenals and testes, J Pharmacol Exp Ther, vol.260, pp.909-925, 1992.

M. P. Soares, Y. Lin, J. Anrather, E. Csizmadia, K. Takigami et al., Expression of heme oxygenase-1 can determine cardiac xenograft survival, Nat Med, vol.4, pp.1073-1080, 1998.

G. Silva, A. Cunha, I. P. Grégoire, M. P. Seldon, and M. P. Soares, The antiapoptotic effect of heme oxygenase-1 in endothelial cells involves the degradation of p38 alpha MAPK isoform, J Immunol, vol.177, pp.1894-903, 2006.

G. B. Atkins and M. K. Jain, Role of Krüppel-like transcription factors in endothelial biology, Circ Res, vol.100, pp.1686-95, 2007.

F. Ali, M. Zakkar, K. Karu, E. A. Lidington, S. S. Hamdulay et al., Induction of the cytoprotective enzyme heme oxygenase-1 by statins is enhanced in vascular endothelium exposed to laminar shear stress and impaired by disturbed flow, J Biol Chem, vol.284, pp.18882-92, 2009.

Z. Laszik, A. Mitro, F. B. Taylor, G. Ferrell, and C. T. Esmon, Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway, Circulation, vol.96, pp.3633-3673, 1997.

S. E. Sartain, N. A. Turner, and J. L. Moake, Brain microvascular endothelial cells exhibit lower activation of the alternative complement pathway than glomerular microvascular endothelial cells, J Biol Chem, vol.293, pp.7195-208, 2018.

M. Sullivan, L. A. Rybicki, A. Winter, M. M. Hoffmann, S. Reiermann et al., Age-related penetrance of hereditary atypical hemolytic uremic syndrome, Ann Hum Genet, vol.75, pp.639-686, 2011.

M. Morigi, M. Galbusera, S. Gastoldi, M. Locatelli, S. Buelli et al., Alternative pathway activation of complement by Shiga Toxin promotes exuberant C3a formation that triggers microvascular thrombosis, J Immunol, vol.187, 2011.

M. Noris, M. Galbusera, S. Gastoldi, P. Macor, F. Banterla et al., Dynamics of complement activation in aHUS and how to monitor eculizumab therapy, Blood, vol.124, pp.1715-1741, 2014.

A. W. Pawluczkowycz, M. A. Lindorfer, J. N. Waitumbi, and R. P. Taylor, Hematin promotes complement alternative pathway-mediated deposition of C3 activation fragments on human erythrocytes: potential implications for the pathogenesis of anemia in malaria, J Immunol, vol.179, pp.5543-52, 2007.

M. A. Lindorfer, E. M. Cook, E. S. Reis, D. Ricklin, A. M. Risitano et al., Compstatin Cp40 blocks hematin-mediated deposition of C3b fragments on erythrocytes: Implications for treatment of malarial anemia, Clin Immunol, vol.171, pp.32-37, 2016.

L. T. Roumenina, M. Radanova, B. P. Atanasov, K. T. Popov, S. V. Kaveri et al., Heme interacts with c1q and inhibits the classical complement pathway, J Biol Chem, vol.286, pp.16459-69, 2011.

N. S. Merle, A. Grunenwald, H. Rajaratnam, V. Gnemmi, M. Frimat et al., Intravascular hemolysis activates complement via cellfree heme and heme-loaded microvesicles, JCI Insight, vol.3, p.96910, 2018.

M. Durey, A. Sinha, S. K. Togarsimalemath, and A. Bagga, Anti-complementfactor H-associated glomerulopathies, Nat Rev Nephrol, vol.12, pp.563-78, 2016.

L. Quintrec, M. Roumenina, L. Noris, M. Frémeaux-bacchi, and V. , Atypical hemolytic uremic syndrome associated with mutations in complement regulator genes, Semin Thromb Hemost, vol.36, pp.641-52, 2010.

M. Heurich, R. Preston, O. Donnell, V. B. Morgan, B. P. Collins et al., Thrombomodulin enhances complement regulation through strong affinity interactions with factor H and C3b-Factor H complex, Thromb Res, vol.145, pp.84-92, 2016.

K. Tateishi, M. Imaoka, and M. Matsushita, Dual modulating functions of thrombomodulin in the alternative complement pathway, Biosci Trends, vol.10, pp.231-235, 2016.

Z. D. Békássy, A. Kristoffersson, J. Rebetz, R. Tati, A. I. Olin et al., Aliskiren inhibits renin-mediated complement activation, Kidney Int, vol.94, pp.689-700, 2018.

K. Benz and K. Amann, Pathological aspects of membranoproliferative glomerulonephritis (MPGN) and haemolytic uraemic syndrome (HUS) / thrombocytic thrombopenic purpura (TTP), Thromb Haemost, vol.101, pp.265-70, 2009.

M. A. Lusco, A. B. Fogo, B. Najafian, and C. E. Alpers, AJKD Atlas of renal pathology: thrombotic microangiopathy, Am J Kidney Dis, vol.68, 2016.

A. Yachie, Y. Niida, T. Wada, N. Igarashi, H. Kaneda et al., Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency, J Clin Invest, vol.103, pp.129-164, 1999.

N. Chen, W. Shao, P. Lv, S. Zhang, Y. Chen et al., Hemininduced Erk1/2 activation and heme oxygenase-1 expression in human umbilical vein endothelial cells, Free Radic Res, vol.41, pp.990-996, 2007.

S. J. Wilson and A. K. Keenan, Role of hemin in the modulation of H2O2mediated endothelial cell injury, Vascul Pharmacol, vol.40, pp.109-127, 2003.

K. A. Nath, J. P. Grande, J. J. Haggard, A. J. Croatt, Z. S. Katusic et al., Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease, Am J Pathol, vol.158, pp.893-903, 2001.

N. G. Abraham, R. Rezzani, L. Rodella, A. Kruger, D. Taller et al., Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes, Am J Physiol Heart Circ Physiol, vol.287, pp.2468-77, 2004.

Z. Li, Y. Wang, and P. M. Vanhoutte, Upregulation of heme oxygenase 1 by hemin impairs endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat, Hypertension, vol.58, pp.926-960, 2011.

X. Zhang, E. L. Bedard, R. Potter, R. Zhong, J. Alam et al., Mitogenactivated protein kinases regulate HO-1 gene transcription after ischemiareperfusion lung injury, Am J Physiol Lung Cell Mol Physiol, vol.283, pp.815-844, 2002.

N. Lindenblatt, R. Bordel, W. Schareck, M. D. Menger, and B. Vollmar, Vascular Heme Oxygenase-1 induction suppresses microvascular thrombus formation in vivo, Arterioscler Thromb Vasc Biol, vol.24, pp.601-607, 2004.

L. Kang, M. L. Hillestad, J. P. Grande, A. J. Croatt, M. A. Barry et al., Induction and functional significance of the heme oxygenase system in pathological shear stress in vivo, Am J Physiol Heart Circ Physiol, vol.308, pp.1402-1415, 2015.

M. Shepard, P. Dhulipala, S. Kabaria, N. G. Abraham, and E. A. Lianos, Heme oxygenase-1 localization in the rat nephron, Nephron, vol.92, pp.660-664, 2002.

Y. Yang, K. Ohta, M. Shimizu, K. Morimoto, C. Goto et al., Selective protection of renal tubular epithelial cells by heme oxygenase (HO)-1 during stress-induced injury, Kidney Int, vol.64, pp.1302-1311, 2003.

K. Mosley, D. E. Wembridge, V. Cattell, and H. T. Cook, Heme oxygenase is induced in nephrotoxic nephritis and hemin, a stimulator of heme oxygenase synthesis, ameliorates disease, Kidney Int, vol.53, pp.672-680, 1998.

A. Kawashima, Y. Oda, A. Yachie, S. Koizumi, and I. Nakanishi, Heme oxygenase1 deficiency: the first autopsy case, Hum Pathol, vol.33, pp.125-155, 2002.

K. Ohta, A. Yachie, K. Fujimoto, H. Kaneda, T. Wada et al., Tubular injury as a cardinal pathologic feature in human heme oxygenase-1 deficiency

, Am J Kidney Dis, vol.35, pp.863-70, 2000.

S. Petrillo, D. Chiabrando, T. Genova, V. Fiorito, G. Ingoglia et al., Heme accumulation in endothelial cells impairs angiogenesis by triggering paraptosis, Cell Death Differ, vol.25, pp.573-88, 2018.

A. Abdelbaset-ismail, S. Borkowska-rzeszotek, E. Kubis, K. Bujko, K. Brzezniakiewicz-janus et al., Activation of the complement cascade enhances motility of leukemic cells by downregulating expression of HO-1, Leukemia, vol.31, pp.446-58, 2017.

F. Schaefer, G. Ardissino, G. Ariceta, F. Fakhouri, M. Scully et al., Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome, Arterioscler Thromb Vasc Biol, vol.94, pp.1339-1385, 2008.

A. Wuestenberg, J. Kah, K. Singethan, H. Sirma, A. D. Keller et al., Matrix conditions and KLF2-dependent induction of heme oxygenase-1 modulate inhibition of HCV replication by fluvastatin, PloS ONE, vol.9, p.96533, 2014.

K. Tsoyi, A. M. Geldart, H. Christou, X. Liu, S. W. Chung et al., Elk3 is a KLF4-regulated gene that modulates the phagocytosis of bacteria by macrophages, J Leukoc Biol, vol.97, pp.171-80, 2015.

F. Modde, P. A. Agustian, J. Wittig, M. E. Dämmrich, V. Forstmeier et al., Comprehensive analysis of glomerular mRNA expression of pro-and antithrombotic genes in atypical haemolytic-uremic syndrome (aHUS), Virchows Arch Int J Pathol, vol.462, pp.455-64, 2013.

J. D. Belcher, C. Chen, J. Nguyen, F. Abdulla, P. Zhang et al., Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction, PLoS ONE, vol.13, 2018.

D. J. Schaer, P. W. Buehler, A. I. Alayash, J. D. Belcher, and G. M. Vercellotti, Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins, Blood, vol.121, pp.1276-84, 2013.

, Conflict of Interest Statement: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest

. Copyright-©-;-merle, . Grunenwald, . Gnemmi, . Leon, . Payet et al., This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, 2018.